BHC Bausch Health Companies Inc

Price (delayed)

$8.545

Market cap

$3.12B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.62

Enterprise value

$24.55B

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of ...

Highlights
Bausch Health Companies's quick ratio has increased by 15% YoY and by 6% from the previous quarter
The revenue has increased by 8% year-on-year and by 2.5% since the previous quarter
The net income has plunged by 163% YoY but it has grown by 39% from the previous quarter
BHC's EPS has dropped by 161% year-on-year but it is up by 39% since the previous quarter
The debt has increased by 8% year-on-year

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
365.41M
Market cap
$3.12B
Enterprise value
$24.55B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.36
EV/EBIT
25.65
EV/EBITDA
11.05
EV/Sales
2.8
Earnings
Revenue
$8.76B
EBIT
$957M
EBITDA
$2.22B
Free cash flow
$760M
Per share
EPS
-$1.62
Free cash flow per share
$2.08
Book value per share
-$2.8
Revenue per share
$24
TBVPS
$26.61
Balance sheet
Total assets
$27.35B
Total liabilities
$27.43B
Debt
$22.39B
Equity
-$1.02B
Working capital
$1.29B
Liquidity
Debt to equity
-21.91
Current ratio
1.3
Quick ratio
0.69
Net debt/EBITDA
9.65
Margins
EBITDA margin
25.4%
Gross margin
70.8%
Net margin
-6.8%
Operating margin
11%
Efficiency
Return on assets
-2.2%
Return on equity
N/A
Return on invested capital
3.7%
Return on capital employed
4.2%
Return on sales
10.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
-0.18%
1 week
-0.64%
1 month
-9.86%
1 year
20.01%
YTD
6.55%
QTD
-19.46%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.76B
Gross profit
$6.2B
Operating income
$963M
Net income
-$592M
Gross margin
70.8%
Net margin
-6.8%
The company's operating income has surged by 164% QoQ and by 112% YoY
The net income has plunged by 163% YoY but it has grown by 39% from the previous quarter
The operating margin has soared by 156% from the previous quarter and by 96% YoY
The net margin has dropped by 143% year-on-year but it has increased by 40% since the previous quarter

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.36
EV/EBIT
25.65
EV/EBITDA
11.05
EV/Sales
2.8
BHC's EPS has dropped by 161% year-on-year but it is up by 39% since the previous quarter
The company's equity fell by 48% YoY but it rose by 13% QoQ
The price to sales (P/S) is 55% lower than the 5-year quarterly average of 0.8 but 20% higher than the last 4 quarters average of 0.3
The revenue has increased by 8% year-on-year and by 2.5% since the previous quarter

Efficiency

How efficient is Bausch Health Companies business performance
The ROA has plunged by 175% YoY but it has grown by 41% from the previous quarter
BHC's return on sales has surged by 70% since the previous quarter but it is down by 33% year-on-year
BHC's return on invested capital has surged by 68% since the previous quarter but it is down by 30% year-on-year

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
The current ratio has grown by 20% YoY and by 8% from the previous quarter
Bausch Health Companies's quick ratio has increased by 15% YoY and by 6% from the previous quarter
The company's equity fell by 48% YoY but it rose by 13% QoQ
The debt to equity is up by 27% year-on-year but it has declined by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.